Search research articles
Contact Us
Filters
Showing results (1-10 of 202) with videos related to
Page
of 21
Sort By:
Pharmacoeconomics
|
September 18, 2009
Comparing three software tools for implementing markov models for health economic evaluations
Petra Menn, Rolf Holle
Health and Quality of Life Outcomes
|
April 20, 2010
Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ
Petra Menn, Norbert Weber, Rolf Holle
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 16, 2011
Analysis of SF-6D index data: is beta regression appropriate?
Matthias Hunger, Jens Baumert, Rolf Holle
Health Policy (Amsterdam, Netherlands)
|
February 7, 2015
The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention
Christian Becker, Rolf Holle, Björn Stollenwerk
Dementia and Geriatric Cognitive Disorders Extra
|
April 18, 2017
Effects of Nursing Home Residency on Diabetes Care in Individuals with Dementia: An Explorative Analysis Based on German Claims Data
Larissa Schwarzkopf, Rolf Holle, Michaela Schunk
Pharmacoeconomics
|
July 18, 2012
A lifetime Markov model for the economic evaluation of chronic obstructive pulmonary disease
Petra Menn, Reiner Leidl, Rolf Holle
BMC Health Services Research
|
September 6, 2012
Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening
Astrid Langer, Rolf Holle, Jürgen John
BMC Medical Research Methodology
|
September 19, 2012
Longitudinal beta regression models for analyzing health-related quality of life scores over time
Matthias Hunger, Angela Döring, Rolf Holle
Plos One
|
June 13, 2019
"Age matters"-German claims data indicate disparities in lung cancer care between elderly and young patients
Julia Walter, Amanda Tufman, Rolf Holle, et al.
Pharmacoeconomics
|
September 1, 2018
Exploring Different Strategies of Assessing the Economic Impact of Multiple Diabetes-Associated Complications and Their Interactions: A Large Claims-Based Study in Germany
Katharina Kähm, Michael Laxy, Udo Schneider, et al.
Page
of 21
Search research articles
Search
Showing results (1-10 of 202) with videos related to
Sort By:
Page
of 21
Pharmacoeconomics
|
September 18, 2009
Comparing three software tools for implementing markov models for health economic evaluations
Petra Menn, Rolf Holle
Health and Quality of Life Outcomes
|
April 20, 2010
Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ
Petra Menn, Norbert Weber, Rolf Holle
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 16, 2011
Analysis of SF-6D index data: is beta regression appropriate?
Matthias Hunger, Jens Baumert, Rolf Holle
Health Policy (Amsterdam, Netherlands)
|
February 7, 2015
The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention
Christian Becker, Rolf Holle, Björn Stollenwerk
Dementia and Geriatric Cognitive Disorders Extra
|
April 18, 2017
Effects of Nursing Home Residency on Diabetes Care in Individuals with Dementia: An Explorative Analysis Based on German Claims Data
Larissa Schwarzkopf, Rolf Holle, Michaela Schunk
Pharmacoeconomics
|
July 18, 2012
A lifetime Markov model for the economic evaluation of chronic obstructive pulmonary disease
Petra Menn, Reiner Leidl, Rolf Holle
BMC Health Services Research
|
September 6, 2012
Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening
Astrid Langer, Rolf Holle, Jürgen John
BMC Medical Research Methodology
|
September 19, 2012
Longitudinal beta regression models for analyzing health-related quality of life scores over time
Matthias Hunger, Angela Döring, Rolf Holle
Plos One
|
June 13, 2019
"Age matters"-German claims data indicate disparities in lung cancer care between elderly and young patients
Julia Walter, Amanda Tufman, Rolf Holle, et al.
Pharmacoeconomics
|
September 1, 2018
Exploring Different Strategies of Assessing the Economic Impact of Multiple Diabetes-Associated Complications and Their Interactions: A Large Claims-Based Study in Germany
Katharina Kähm, Michael Laxy, Udo Schneider, et al.
Page
of 21